DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Contribución de congreso (ConferenceOutput)
Proinsulin therapy protects against neuroinflammaging and cognitive loss in senescence-accelerated mice
Trabajo presentado en el IUBMB Focused Meeting on «Molecular aspects of aging and longevity», celebrado en Atenas, del 16 al 19 de octubre de 2017, Chronic low-grade neuroinflammation is tightly associated with brain age-related
changes and it is considered a crucial derangement that paves the way to
neurodegeneration and dementia. Among other ailments, inflammation may lead to
insulin resistance that is a risk factor for Alzheimer’s disease. In this scenario, the
hormone precursor proinsulin may have a potential pharmacological use in
preventing neuronal death. Proinsulin is a bioactive molecule regulating neural cell
death in embryonic processes and it was proven neuroprotective in mouse models of
retinal neurodegeneration. We aimed to prove the geroprotective effect of a chronic
proinsulin treatment against neuroinflammaging and memory loss in the
senescence-accelerated mouse SAMP8. We used a gene therapy procedure
through peripheral muscle transduction with an adeno-associated viral vector
bearing the human proinsulin gene (AAV-hPi) that yielded sustained release of
proinsulin into the bloodstream. One-month old male mice of the SAMP8 strain and
the control strain SAMR1 were injected with AAV-hPi or AAV-null vectors. At 6
months of age, proinsulin-treated SAMP8 mice showed totally preserved cognitive
capacities both in spatial and recognition paradigms of learning and memory, in
contrast to those SAMP8 mice injected with the null vector. Hippocampus analysis
showed that proinsulin activated Akt and ATF1/CREB signaling pathways in both
SAMR1 and SAMP8 mice. Furthermore, we identified a significant decrease of
neuroinflammatory markers in the hippocampus of SAMP8 mice to levels of SAMR1
mice. Strikingly, the marker of astrocyte reactivity GFAP was decreased in both
SAMR1 and SAMP8. Furthermore, the connectome network build with all changes
induced by proinsulin showed that the decrease of astrocyte reactivity was a central
effect in proinsulin neuroprotection. Therefore, the preventive and protective effects
of human proinsulin against neuroinflammaging and senescence-related cognitive
loss unveil a potential geroprotective therapy to increase healthy brain aging., This study was supported by CSD2010-00045, SAF2016-77703-C2-2-R, MTM2014-60127-P, MINECO and ERDF; PET08-0282, TRACE., Peer reviewed